Literature DB >> 1766940

Race and gender differences in serum lipoproteins of children, adolescents, and young adults--emergence of an adverse lipoprotein pattern in white males: the Bogalusa Heart Study.

S R Srinivasan1, W Wattigney, L S Webber, G S Berenson.   

Abstract

METHODS: Serum lipoprotein profiles in 4,231 individuals, ages 5-26 years, were studied cross-sectionally in a biracial community to describe the race- and gender-specific changes from adolescence into young adulthood.
RESULTS: White children and adolescents of both genders showed significantly higher covariates--adjusted triglycerides (9-11 mg/dl) and very-low-density lipoprotein cholesterol (1-2 mg/dl)--and lower total cholesterol (3-14 mg/dl) and high-density lipoprotein cholesterol (6-10 mg/dl) levels than their black counterparts. These black-white differences persisted among young adults of both genders with the exception of total cholesterol levels (higher triglycerides: 23-32 mg/dl; higher very-low-density lipoprotein cholesterol: 5-7 mg/dl; lower high-density lipoprotein cholesterol: 9-11 mg/dl); in addition, white young adult males began to show higher levels of low-density lipoprotein cholesterol (14 mg/dl) than black young adult males. A consistent gender-related pattern emerged only among white young adults with males showing higher triglyceride levels (22 mg/dl), very-low-density lipoprotein cholesterol (5 mg/dl), and low-density lipoprotein cholesterol (10 mg/dl) and lower high-density lipoprotein cholesterol (10 mg/dl) than females. Lipoprotein changes from adolescence into young adulthood were more pronounced among white males than other race-gender groups, resulting in higher triglyceride, very-low-density lipoprotein cholesterol, and low-density lipoprotein cholesterol, a higher total cholesterol/high-density lipoprotein cholesterol ratio, and a lower high-density lipoprotein cholesterol in their young adulthood. According to the National Cholesterol Education Program criteria, a relatively higher proportion of young adult white males was classified as borderline-high (22.6%) or high (9.1%) for low-density lipoprotein cholesterol. Adiposity was the major contributor to the adverse lipoprotein pattern, especially among white males. Sexual maturation and age influenced the lipoprotein levels to a greater extent among white males. Cigarette smoking, alcohol intake, and oral contraceptive use began to emerge as minor but significant factors contributing to the lipoprotein levels in adolescents and young adults.
CONCLUSION: These results underscore the desirability of early targeting for primary prevention.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1766940     DOI: 10.1016/0091-7435(91)90063-a

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  5 in total

1.  Ethnic differences in lipid and lipoprotein metabolism in pregnant women of African and Caucasian origin.

Authors:  E Koukkou; G F Watts; J Mazurkiewicz; C Lowy
Journal:  J Clin Pathol       Date:  1994-12       Impact factor: 3.411

2.  Fat distribution, aerobic fitness, blood lipids, and insulin sensitivity in African-American and European-American women.

Authors:  Gary R Hunter; Paula C Chandler-Laney; David W Brock; Cristina Lara-Castro; Jose R Fernandez; Barbara A Gower
Journal:  Obesity (Silver Spring)       Date:  2009-08-06       Impact factor: 5.002

3.  Changes in Fasting Lipids during Puberty.

Authors:  Mona A Eissa; Nicole L Mihalopoulos; Richard Holubkov; Shifan Dai; Darwin R Labarthe
Journal:  J Pediatr       Date:  2015-12-22       Impact factor: 4.406

4.  Sex Differences in Association of Elevated Blood Pressure with Variables Characterizing Cardiometabolic Risk in Young Subjects with or Without Metabolic Abnormalities.

Authors:  Katarína Šebeková; Radana Gurecká; Melinda Csongová; Ivana Koborová; Jozef Šebek
Journal:  Int J Environ Res Public Health       Date:  2020-05-21       Impact factor: 3.390

5.  Sex differences in responses to antiretroviral treatment in South African HIV-infected children on ritonavir-boosted lopinavir- and nevirapine-based treatment.

Authors:  Stephanie Shiau; Louise Kuhn; Renate Strehlau; Leigh Martens; Helen McIlleron; Sandra Meredith; Lubbe Wiesner; Ashraf Coovadia; Elaine J Abrams; Stephen M Arpadi
Journal:  BMC Pediatr       Date:  2014-02-12       Impact factor: 2.125

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.